Ignite Creation Date:
2024-05-06 @ 10:51 AM
Last Modification Date:
2024-10-26 @ 12:36 PM
Study NCT ID:
NCT03366142
Status:
COMPLETED
Last Update Posted:
2024-05-24
First Post:
2017-12-07
Brief Title:
Ustekinumab Anti-IL-1223p40 Monoclonal Antibody in Patients With Leukocyte Adhesion Deficiency Type 1 LAD1 Who Have Inflammatory Pathology
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-02
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2017-12-07
First Submit QC Date:
December 7 2017
Study First Post Date:
2017-12-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-19
Last Update Post Date:
2024-05-24
Last Update Post Date Type:
ACTUAL